Heart disease and stroke statistics—2019 update: a report from the American Heart Association
EJ Benjamin, P Muntner, A Alonso, MS Bittencourt… - Circulation, 2019 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …
Institutes of Health and other government agencies, brings together in a single document the …
Heart disease and stroke statistics—2018 update: a report from the American Heart Association
EJ Benjamin, SS Virani, CW Callaway… - Circulation, 2018 - Am Heart Assoc
Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …
for Disease Control and Prevention, the National Institutes of Health, and other government …
Clinical use of intracoronary imaging. Part 2: Acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: An …
TW Johnson, L Räber, C Di Mario… - European heart …, 2019 - academic.oup.com
This consensus document is the second of two reports summarizing the views of an expert
panel organized by the European Association of Percutaneous Cardiovascular Interventions …
panel organized by the European Association of Percutaneous Cardiovascular Interventions …
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations
Introduction Clopidogrel is the most frequently utilized P2Y12 inhibitor and is characterized
by broad interindividual response variability resulting in impaired platelet inhibition and …
by broad interindividual response variability resulting in impaired platelet inhibition and …
Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome―The ODYSSEY J-IVUS Trial―
J Ako, K Hibi, K Tsujita, T Hiro, Y Morino… - Circulation …, 2019 - jstage.jst.go.jp
Background: In patients with acute coronary syndrome (ACS), alirocumab reduced the risk of
recurring ischemic events. ODYSSEY J-IVUS assessed the effect of alirocumab on coronary …
recurring ischemic events. ODYSSEY J-IVUS assessed the effect of alirocumab on coronary …
One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome―An Analysis of 20,042 Patients From a Japanese Nationwide Registry―
Background: Acute coronary syndrome (ACS) hospital survivors experience a wide array of
late adverse cardiac events, despite considerable advances in the quality of care. We …
late adverse cardiac events, despite considerable advances in the quality of care. We …
Deep-learning-based risk stratification for mortality of patients with acute myocardial infarction
Objective Conventional risk stratification models for mortality of acute myocardial infarction
(AMI) have potential limitations. This study aimed to develop and validate deep-learning …
(AMI) have potential limitations. This study aimed to develop and validate deep-learning …
Risk stratification in acute coronary syndrome by comprehensive morphofunctional assessment with optical coherence tomography
H Hong, H Jia, M Zeng, JL Gutiérrez-Chico, Y Wang… - JACC: Asia, 2022 - jacc.org
Background Artificial intelligence enables simultaneous evaluation of plaque morphology
and computational physiology from optical coherence tomography (OCT). Objectives This …
and computational physiology from optical coherence tomography (OCT). Objectives This …
[HTML][HTML] Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper
P Sabouret, G Lemesle… - Archives of Medical …, 2022 - ncbi.nlm.nih.gov
Results The International Collaborative Group underlines the need of a shared collaborative
approach, and a care plan individualized to the patient's risk profile for both ischaemia and …
approach, and a care plan individualized to the patient's risk profile for both ischaemia and …